Unexpected random urinary protein: Creatinine ratio results-limitations of the pyrocatechol violet-dye method

BMC Pregnancy and Childbirth

Volumn 13, Issue , 2013, Pages

  De Silva, Dane A ^a   Halstead, Anne C ^a   Côté, Anne Marie ^b   Sabr, Yasser ^a   von Dadelszen, Peter ^a,d   Magee, Laura A ^a,c,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Hypertension; Laboratory; Pre eclampsia; Pregnancy; Protein:creatinine ratio; Proteinuria measurement

Indexed keywords

CATECHOL; PYROGALLOL; BENZENESULFONIC ACID DERIVATIVE; COLORING AGENT; CREATININE; PYROCATECHOL VIOLET; PYROGALLOL SULFONPHTHALEIN;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONCENTRATION (PARAMETERS); CREATININE URINE LEVEL; FEMALE; HUMAN; IONIC STRENGTH; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; PATIENT CARE; PREGNANCY OUTCOME; PREGNANT WOMAN; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; SECOND TRIMESTER PREGNANCY; TOTAL QUALITY MANAGEMENT; URINARY PROTEIN CREATININE RATIO; UROGENITAL SYSTEM PARAMETERS; ANALOGS AND DERIVATIVES; COHORT ANALYSIS; DIAGNOSTIC USE; LABORATORY DIAGNOSIS; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; STANDARDS; URINALYSIS; URINE;

ADULT; BENZENESULFONATES; COHORT STUDIES; COLORING AGENTS; CREATININE; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; PROTEINURIA; PYROGALLOL; URINALYSIS;

EID: 84880183687     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-13-152     Document Type: Article

References (15)

1. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39(2 Suppl 1):S1-S266. National Kidney Foundation.
2. Magee LA, Helewa M, Rey E, Cote AM, Douglas J, Gibson P, et al. SOGC clinical practice guideline: diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. JOGC 2008, 30(Suppl 3):S1-S48.
3. Clark WF, Kortas C, Suri RS, Moist LM, Salvadori M, Weir MA, et al. Excessive fluid intake as a novel cause of proteinuria. CMAJ 2008, 178(2):173-175. 2175005, 18195291.
4. Ortho-Clinical Diagnostics Instructions for use: Vitros Chemistry Products CREA Slides 2007, Rochester, NY: Ortho-Clinical Diagnostics, Ortho-Clinical Diagnostics.
5. Ortho-Clinical Diagnostics Instructions for use: Vitros Chemistry Products UPRO Slides 2010, Rochester, NY: Ortho-Clinical Diagnostics, Ortho-Clinical Diagnostics.
6. Cote AM, Firoz T, Mattman A, Lam EM, Von Dadelszen P, Magee LA. The 24-hour urine collection: gold standard or historical practice?. Am J Obstet Gynecol 2008, 199(6):625-626.
7. Von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton PF, Cote AM, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet 2011, 377(9761):219-227. 10.1016/S0140-6736(10)61351-7, 21185591.
8. Koopmans CM, Biilenga D, Groen H, Vijgen SM, Aarnoudse JG, Bekedam DJ, et al. Induction of labour verses expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 2009, 374(9694):979-988. 10.1016/S0140-6736(09)60736-4, 19656558.
9. Magee LA, Yong PJ, Espinosa V, Cote AM, Chen I, Von Dadelszen P. Expectant management of severe Preeclampsia remote from term: a structured systematic review. Hypertens Pregnancy 2009, 28(3):312-347. 10.1080/10641950802601252, 19277923.
10. De Buys Roessingh AS, Drukker A, Guignard JP. Dipstick measurements of urine specific gravity are unreliable. Arch Dis Child 2001, 85(2):155-157. 10.1136/adc.85.2.155, 1718890, 11466191.
11. Dube J, Girouard J, Leclerc P, Douville P. Problems with the estimation of urine protein by automated assays. Clin Biochem 2005, 38(5):479-485. 10.1016/j.clinbiochem.2004.12.010, 15820780.
12. Lynch PLM, Savory J, Haverstick DM. Urine total protein measurement with the vitros dry reagent technology: modification of diluent to resolve positive bias of diluted samples. Clin Chem 1998, 44(3):674-675.
13. De Silva DA, Halstead AC, Cote AM, Sabr Y, Von Dadelszen P, Magee LA. Random urine albumin:creatinine ratio in high-risk pregnancy - Is it clinically useful?. Preg Hyper: An Int J Women's Card Health 2013, 3(2):112-114.
14. Cote AM, Brown MA, Lam E, Von Dadelszen P, Firoz T, Liston RM, et al. Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review. BMJ 2008, 336(7651):1003-1011. 10.1136/bmj.39532.543947.BE, 2364863, 18403498.
15. Komenda P, Beaulieu M, Seccombe D, Levin A. Regional implementation of creatinine measurement standardization. J Am Soc Nephrol 2009, 19(1):164-169.